Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 36.9% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 71,409 shares of the company's stock after selling 41,800 shares during the quarter. New York State Common Retirement Fund owned 0.06% of Henry Schein worth $4,891,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Investment Management Corp VA ADV bought a new position in shares of Henry Schein in the 4th quarter worth approximately $32,000. Rakuten Securities Inc. bought a new stake in Henry Schein during the first quarter valued at about $34,000. UMB Bank n.a. increased its holdings in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the last quarter. Allworth Financial LP increased its stake in Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after acquiring an additional 232 shares during the last quarter. Finally, Menard Financial Group LLC purchased a new stake in shares of Henry Schein in the fourth quarter valued at approximately $92,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on HSIC shares. Barrington Research reduced their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Stifel Nicolaus restated a "hold" rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a report on Friday. Piper Sandler decreased their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research report on Wednesday, April 30th. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Finally, Robert W. Baird reiterated a "neutral" rating and set a $72.00 price target (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, Henry Schein presently has a consensus rating of "Hold" and a consensus target price of $78.08.

Henry Schein Trading Down 1.6%

Shares of HSIC stock traded down $1.16 during mid-day trading on Friday, reaching $71.46. The company's stock had a trading volume of 2,049,718 shares, compared to its average volume of 1,564,422. The company's 50 day simple moving average is $71.90 and its 200-day simple moving average is $71.38. The firm has a market capitalization of $8.70 billion, a PE ratio of 22.33, a price-to-earnings-growth ratio of 2.35 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period in the previous year, the business posted $1.10 EPS. The company's quarterly revenue was down .1% on a year-over-year basis. On average, research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.